Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2008
Site-specific modification of AAV vector particles with biophysical probes and targeting ligands using biotin ligaseMatthew D Stachler, Irwin Chen, Alice Y Ting, et al.
Human Pathology|February 17, 2015
Novel molecular insights from routine genotyping of colorectal carcinomasMatthew D Stachler, Elizabeth Rinehart, Neal Lindeman, et al.
Gastroenterology Clinics of North America|May 30, 2015
Genetic and Epigenetic Alterations in Barrett's Esophagus and Esophageal AdenocarcinomaAndrew M Kaz, William M Grady, Matthew D Stachler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 21, 2006
Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypesGregory S Arnold, A Kate Sasser, Matthew D Stachler, et al.
The Indian Journal of Radiology & Imaging|January 7, 2012
Case report: Calcifying fibrous tumor presenting as an asymptomatic pelvic massAngela A Giardino, Nikhil H Ramaiya, Atul B Shinagare, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 21, 2018
Clinicopathologic and genetic characteristics of interval colorectal carcinomas favor origin from missed or incompletely excised precursorsThing Rinda Soong, Jennifer Nayor, Matthew D Stachler, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
Histopathology-based Spatial Profiling of Immune and Molecular Features Predicts Cancer risk in Barrett's EsophagusCaner Ercan, Xiaoxi Pan, Thomas G Paulson, et al.
Gastroenterology|November 10, 2021
Abnormal TP53 Predicts Risk of Progression in Patients With Barrett's Esophagus Regardless of a Diagnosis of DysplasiaMark Redston, Amy Noffsinger, Anthony Kim, et al.
Pageof 4